CG5503 Prolonged Release
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CG5503 Prolonged Release, covering 2011-01-11 to 2011-01-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CG5503 Prolonged Release (PR) in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee [Phase 3]